A thirty-three gene-based signature predicts lymph node metastasis and prognosis in patients with gastric cancer
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81874219)
- National Natural Science Foundation of China (LC2021001)
This publication has 29 references indexed in Scilit:
- Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastasesGastric Cancer, 2014
- Tumor metastasis: moving new biological insights into the clinicNature Medicine, 2013
- The low‐abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancerInternational Journal of Cancer, 2013
- Protein predictive signatures for lymph node metastasis of gastric cancerInternational Journal of Cancer, 2012
- Clinical Significance of Lymph Node Micrometastasis in Gastric CancerAnnals of Surgical Oncology, 2012
- Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinomaHepatology, 2011
- CD83+ dendritic cells and Foxp3+ regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancerGastric Cancer, 2011
- Gene Expression Signature–Based Prognostic Risk Score in Gastric CancerClinical Cancer Research, 2011
- Molecular biology from bench-to-bedside – Which colorectal cancer patients should be referred for genetic counselling and risk assessmentEuropean Journal of Cancer, 2010
- Prediction of Lymph Node Metastasis by Analysis of Gene Expression Profiles in Primary Lung AdenocarcinomasClinical Cancer Research, 2005